Taro Pharmaceuticals
As of the edition of 20 October 2026, Taro Pharmaceuticals runs 6 drugs, 6 of them marketed.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Drugs by status
| Status | Count |
|---|---|
| Marketed | 6 |
| Total | 6 |
Marketed drugs and when their US protection ends
| Drug | US protection | Route B rows |
|---|---|---|
| Ibuprofen | none listed | 11 |
| Prednisolone | none listed | 6 |
| Loratadine | none listed | 2 |
| Prednisolone acetate | none listed | 2 |
| Desoximetasone | none listed | 1 |
| Diflorasone diacetate | none listed | 0 |
A route B row is one company at one target.